| Critical Minerals Group Limited (CMG) ORDINARY FULLY PAID |
Materials |
$15 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 9:22AM |
$0.170 |
$0.165 |
fallen by
2.94%
|
|
CMG - Price-sensitive ASX Announcement
Full Release
Key Points
- CMG completed a Pre-Feasibility Study (PFS) for the Lindfield Vanadium Project, indicating positive technical and economic results.
- Ongoing metallurgical test work and environmental baseline studies are being conducted to support project development.
- Stakeholder engagement with government and landholders has progressed during the period.
- CMG's closing cash balance was $2.90 million as of 30 June 2023.
- The company is focused on advancing the Lindfield project towards future development stages.
- Sound financial management continues, with cash flow reporting and expenditure control in place.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MedAdvisor Limited (MDR) ORDINARY FULLY PAID |
Health Care |
$31 |
MDR 4Q FY25 Quarterly Activity Report and 4C
|
31 Jul 2025 9:22AM |
$0.079 |
$0.050 |
fallen by
36.71%
|
|
MDR - Price-sensitive ASX Announcement
Full Release
Key Points
- MedAdvisor reported strong revenue growth in 4Q FY25.
- Significant progress was made in global digital health programs.
- The company achieved key commercial wins, particularly in the US market.
- Cost management remained a key focus, enabling operational efficiency.
- Expansion of patient engagement and adherence solutions was noted.
- The report details positive cash flow and improved financial position.
- The outlook for the next quarters remains positive, with continued investment in technology and innovation.
- Board and management changes were highlighted as part of ongoing business optimisation.
- The document includes Appendix 4C, providing detailed cash flow information.
- MedAdvisor reaffirmed its commitment to digital healthcare transformation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Augustus Minerals Limited (AUG) ORDINARY FULLY PAID |
Materials |
$8 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 9:22AM |
$0.042 |
$0.050 |
risen by
19.05%
|
|
AUG - Price-sensitive ASX Announcement
Full Release
Key Points
- Augustus Minerals Limited completed an extensive drilling campaign at the Ti-Tree Project.
- Initial assay results indicate promising lithium, copper, and REE mineralisation.
- Geochemical and geophysical surveys identified new high-priority targets for follow-up exploration.
- The company maintains a strong cash position to fund ongoing exploration efforts.
- Cash outflows were primarily directed towards exploration and evaluation activities.
- Preparations are underway for additional drilling and exploration in the upcoming quarter.
- No mining production or development activities were undertaken during the quarter.
- The company is focused on maximising shareholder value through systematic exploration.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Conrad Asia Energy Ltd (CRD) CHESS DEPOSITARY INTERESTS 1:1 |
Energy |
$145 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 9:22AM |
$0.780 |
$0.750 |
fallen by
3.85%
|
|
CRD - Price-sensitive ASX Announcement
Full Release
Key Points
- Conrad Asia Energy Ltd provided a quarterly update for the period ending March 31, 2024.
- Significant progress was made on the Mako Gas Project in Indonesia, including POD approval and regulatory engagement.
- New gas sales agreements and heads of agreement were signed to support project commercialization.
- Exploration and appraisal activities continued, with technical work advancing on key licenses.
- Financial summary includes cash inflows from financing and cash outflows related to exploration and operational activities.
- Company maintains a strong liquidity position and manages capital prudently.
- Ongoing discussions with government authorities and partners to advance upstream and commercial objectives.
- The report provides a detailed breakdown of quarterly cash flow as per Appendix 5B requirements.
- Outlook emphasizes continued efforts to secure project approvals, finalize commercial agreements, and progress developments in the next quarters.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Iltani Resources Limited (ILT) ORDINARY FULLY PAID |
Materials |
$19 |
Maiden Orient West JORC Mineral Resource Estimate
|
31 Jul 2025 9:21AM |
$0.200 |
$0.285 |
risen by
42.50%
|
|
ILT - Price-sensitive ASX Announcement
Full Release
Key Points
- Iltani Resources Limited released a Maiden JORC Mineral Resource Estimate for the Orient West Project.
- The project is located in northern Queensland and contains significant silver, lead, and zinc mineralization.
- Resource estimation follows the guidelines set by JORC 2012.
- The report details geological setting, exploration history, sampling, drilling, and data validation procedures.
- Potential exists for resource expansion with further exploration and drilling.
- All technical data, relevant tables, and statements are included to support estimation transparency.
- The report emphasizes compliance and best practices in resource reporting.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pointerra Limited (3DP) ORDINARY FULLY PAID |
Information Technology |
$38 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2025 9:21AM |
$0.057 |
$0.047 |
fallen by
17.54%
|
|
3DP - Price-sensitive ASX Announcement
Full Release
Key Points
- Pointerra Limited released its Quarterly Activities and Appendix 4C Cash Flow Report for Q3 FY2024.
- The company’s 3D data management platform (3DP) continues to gain traction, especially in the US energy utilities market.
- New contract wins and renewals with existing customers have contributed to ongoing revenue growth.
- Operational highlights include platform enhancements and expansion into new verticals and geographies.
- Cash receipts for the quarter were reported alongside a summary of operating expenditure and available cash.
- Management remains focused on cost control and efficient cash management.
- Compliance with ASX Listing Rules and related party transactions are disclosed.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Winchester Energy Limited (WEL) ORDINARY FULLY PAID |
Energy |
$3 |
Reinstatement to Quotation
|
31 Jul 2025 9:21AM |
$0.001 |
$0.002 |
risen by
100%
|
|
WEL - Price-sensitive ASX Announcement
Full Release
Key Points
- Winchester Energy Limited (WEL) to be reinstated to quotation on ASX.
- Reinstatement follows a period of suspension due to non-compliance with listing rules.
- Company has completed a capital raising as required by the ASX.
- WEL has addressed corporate governance and financial reporting requirements.
- Announcement includes timeline for reinstatement of securities.
- Disclosure obligations remain in place for ongoing transparency.
- Reinstatement was announced on 7 June 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EVE Health Group Limited (EVE) ORDINARY FULLY PAID |
Consumer Staple |
$7 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2025 9:21AM |
$0.034 |
$0.027 |
fallen by
20.59%
|
|
EVE - Price-sensitive ASX Announcement
Full Release
Key Points
- EVE Health Group Limited provided its Quarterly Activities Report and Appendix 4C for the quarter ended 31 March 2024.
- The company continued its focus on the development and commercialization of diagnostic and health technologies.
- Updates were given on product development, regulatory approvals, and partnership initiatives.
- Key operational highlights included progress in clinical studies, product launches, and market expansion strategies.
- Financially, the report included a summary of cash receipts, payments for research and development, product manufacturing, and operating costs.
- The cash flow statement detailed the company’s cash position at the end of the period and highlighted expenditure areas.
- EVE Health Group outlined its strategy for capitalizing on market opportunities and sustaining growth.
- The report confirmed compliance with ASX Listing Rule 4.7C, including details on payments to related parties.
- Future plans include continued investment in proprietary technology, expansion into new markets, and ongoing regulatory engagement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Decidr AI Industries Ltd (DAI) ORDINARY FULLY PAID |
Consumer Staple |
$162 |
June 2025 Quarterly Business Review & Appendix 4C
|
31 Jul 2025 9:20AM |
$0.450 |
$0.780 |
risen by
73.33%
|
|
DAI - Price-sensitive ASX Announcement
Full Release
Key Points
- Reviewed key operational achievements and challenges for the quarter
- Outlined financial performance including receipts, expenses, and net cash position
- Reported on new customer acquisitions and commercial partnership progress
- Detailed ongoing development in AI-driven product offerings
- Summarized updates in sales pipeline growth and revenue generation
- Discussed investment in R&D and platform enhancements
- Explained management of cash flows and funding requirements
- Responded to ASX Appendix 4C compliance items and regulatory questions
- Highlighted strategic outlook and plans for the upcoming quarters
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Winchester Energy Limited (WEL) ORDINARY FULLY PAID |
Energy |
$3 |
Board Appointments
|
31 Jul 2025 9:20AM |
$0.001 |
$0.002 |
risen by
100%
|
|
WEL - Price-sensitive ASX Announcement
Full Release
Key Points
- Announcement of board changes at Winchester Energy Limited (WEL) on 20 November 2023
- Appointment of Tony Gu as Non-Executive Chairman
- Appointment of Peter Mills and David McAuley as Non-Executive Directors
- Resignation of John Kopcheff and Neville Bassett from the board
- Board changes are immediate and part of company’s efforts to strengthen governance
- New directors bring industry experience and expertise to support company growth
- Board composition adjustments align with company’s strategic objectives
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Janus Electric Holdings Limited (JNS) ORDINARY FULLY PAID |
Utilities |
$14 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2025 9:20AM |
$0.150 |
$0.145 |
fallen by
3.33%
|
|
JNS - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly activities report and Appendix 4C cash flow report for the period ending 31 March 2024
- Continued development and commercialisation of electric truck technology
- Completed key technical upgrades and battery swap enhancements
- First on-road trials of electric prime movers conducted
- Established a new collaboration with a global logistics company
- Advanced discussions for pilot programs with major industry players
- Reported net operating cash outflows due to research, development, and administrative expenses
- Maintained sufficient cash reserves for upcoming planned activities
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Core Energy Minerals Ltd (CR3) ORDINARY FULLY PAID |
Materials |
$5 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 9:20AM |
$0.014 |
$0.011 |
fallen by
21.43%
|
|
CR3 - Price-sensitive ASX Announcement
Full Release
Key Points
- CR3 advanced lithium and rare earth element exploration projects in Australia (WA, NT) and Canada.
- Successful grant and acquisition of multiple exploration tenements and license applications.
- Resource definition and drilling programs commenced or planned at highly prospective sites.
- Partnerships and community engagement activities were undertaken with First Nations in Canada.
- CR3 participated in key mining industry events and government delegations.
- Company maintained a strong cash balance, ending the quarter with approximately $5.6 million.
- Exploration and evaluation expenditure for the quarter totaled $1.24 million.
- No mining production or sales occurred during the quarter.
- Detailed Appendix 5B Cash Flow statement included, outlining receipts, payments, and financing activities.
- Compliance statements and a comprehensive list of tenements held, acquired, or applied for were disclosed.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clime Capital Limited (CAM) ORDINARY FULLY PAID |
Financials |
$103 |
Update - Notification of buy-back - CAM
|
31 Jul 2025 9:19AM |
$0.705 |
$0.695 |
fallen by
1.42%
|
|
| Ionic Rare Earths Limited (IXR) ORDINARY FULLY PAID |
Materials |
$97 |
June Quarterly Activities & Cash Flow Report
|
31 Jul 2025 9:19AM |
$0.019 |
$0.017 |
fallen by
10.53%
|
|
IXR - Price-sensitive ASX Announcement
Full Release
Key Points
- Ionic Rare Earths Limited (IonicRE) released its June 2023 Quarterly Activities and Cash Flow Report.
- The Makuutu Rare Earths Project in Uganda remains the company’s primary focus, with continued progress on the Demonstration Plant and ongoing work to support the Feasibility Study and Mining Licence Application.
- The company reported positive developments around resource definition drilling, metallurgical testwork, and completion of the Demonstration Plant, which will provide mixed rare earth carbonate product for offtake discussions.
- Offtake and strategic partnership discussions progressed during the quarter, with multiple parties interested in securing future supply of rare earths from Makuutu.
- Ionic Technologies’ Belfast demonstration plant produced recycled rare earth oxides from end-of-life magnets, advancing its position in rare earth recycling.
- IonicRE continued to engage with multiple potential strategic partners and offtake parties, focusing on supply chain resilience and ESG credentials.
- The company maintained a solid cash position at the end of the quarter, with financials detailed in the accompanying Appendix 5B cash flow report.
- No significant mining production or exploration was conducted outside the main Makuutu Project area.
- Future work will include completion of the Demonstration Plant activities, further engagement with potential partners, and advancing the Makuutu Project towards development.
- There were no payments to related parties during the quarter except for Board and management fees.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| xReality Group Ltd (XRG) ORDINARY FULLY PAID |
Consumer Discretionary |
$37 |
Quarterly Activities Report and Appendix 4C - 30 Jun 25
|
31 Jul 2025 9:19AM |
$0.027 |
$0.049 |
risen by
81.48%
|
|
XRG - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly Activities Report and Appendix 4C released for the quarter ending 30 June 2025.
- Growth in recurring revenue from digital reality training solutions.
- Successful development and release of new training modules and platform features.
- Increased engagement with government, law enforcement, and enterprise clients.
- Expansion of market reach through new partnerships and international projects.
- Strong cash balance and disciplined expenditure management.
- Continued investment in technology and innovation.
- Focus on scaling operations and delivering value to shareholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Micro-X Limited (MX1) ORDINARY FULLY PAID |
Health Care |
$58 |
MX1 - Quarterly Activities Report & Appendix 4C
|
31 Jul 2025 9:19AM |
$0.086 |
$0.087 |
risen by
1.16%
|
|
MX1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Reported quarterly cash receipts of $1.6 million, with closing cash balance of $7.7 million as at 31 March 2024.
- Revenue was primarily driven by Mobile DR sales in both Australian and US markets.
- Continued progress in Checkpoints, including delivery and installation of new technology for US Transportation Security Administration (TSA) trials.
- Argus project advanced with further engineering milestones and ongoing engagement with potential customers in defence and security sectors.
- CT business unit made strides towards commercialization, with technology development and initial market engagement.
- Ongoing cost control measures were implemented to manage cash burn and extend operational runway.
- Research and development remains a significant focus, with investments in new technology platforms.
- No significant changes in related party transactions during the quarter.
- Directors are confident of meeting medium-term operational and financial objectives.
- Funding and capital management remain priorities, with the company actively exploring opportunities to strengthen financial position.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| iTech Minerals Ltd (ITM) ORDINARY FULLY PAID |
Materials |
$8 |
Quarterly Activities and Cashflow Report 30 June 2025
|
31 Jul 2025 9:19AM |
$0.031 |
$0.047 |
risen by
51.61%
|
|
ITM - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly report covers activities and cashflow for the period ending 30 June 2025.
- Continued exploration and development of graphite, kaolin, and rare earth element projects in South Australia.
- Successful metallurgical test work and drilling programs at Campoona Graphite Project.
- Positive progress in scoping studies for the Ethiopia Kaolin Project.
- Advancements in rare earth element exploration and analysis.
- Engagement with potential offtake and strategic partners.
- Detailed cashflow statement showing exploration, administrative expenditures, and closing cash balance.
- Company remains focused on resource estimation, feasibility assessments, and downstream processing opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Electro Optic Systems Holdings Limited (EOS) ORDINARY FULLY PAID |
Industrials |
$1,453 |
Quarterly Activity Report and Appendix 4C - June 2025
|
31 Jul 2025 9:19AM |
$3.050 |
$7.530 |
risen by
146.89%
|
|
EOS - Price-sensitive ASX Announcement
Full Release
Key Points
- EOS reported on key operational activities and progress across its Space, Defence, and Communications divisions for the quarter ending June 30, 2025.
- The report outlines significant contract wins, ongoing project deliverables, and new business opportunities.
- Financial highlights include cash receipts, payments, and overall net cash flow; expenditures covered research and development, product manufacturing, and administrative costs.
- EOS described its liquidity position and financial strategy, addressing funding, cash reserves, and future capital requirements.
- The company provided updates on major projects and partnerships, emphasizing engagement with government and international customers.
- EOS noted prevailing risks, including supply chain challenges, geopolitical uncertainties, and market competition.
- Market outlook and future strategy were discussed, with a focus on growth in defence, space, and communications technologies.
- The Appendix 4C included a detailed cash flow statement for the reporting period.
- No material changes in related party transactions or payments were reported for the quarter.
- The report reaffirmed the company’s commitment to delivering on its long-term strategic objectives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Great Divide Mining Ltd (GDM) ORDINARY FULLY PAID |
Materials |
$17 |
Quarterly Activities and Cashflow Reports
|
31 Jul 2025 9:19AM |
$0.420 |
$0.385 |
fallen by
8.33%
|
|
GDM - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly report covers activities for the period ending 31 March 2023.
- Significant progress reported at core exploration projects.
- Exploration activities included drilling, mapping, and sampling.
- Resource evaluation and expansion strategies discussed.
- Corporate developments included updates on tenement holdings and approvals.
- Summary of expenditure and cash outflows provided.
- Cashflow report highlights operational and investing activities.
- Company remains focused on advancing exploration and resource development.
- No production or sales revenue generated during the period.
- Company maintains adequate cash reserves to fund near-term objectives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Doctor Care Anywhere Group PLC (DOC) CHESS DEPOSITARY INTERESTS 1:1 |
Health Care |
$66 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2025 9:18AM |
$0.130 |
$0.180 |
risen by
38.46%
|
|
DOC - Price-sensitive ASX Announcement
Full Release
Key Points
- Doctor Care Anywhere Group PLC (DOC) released its Appendix 4C and Quarterly Activities Report for the quarter ended 31 March 2023.
- DOC reported a reduction in quarterly cash burn to £1.6 million, down from £2.8 million in the previous quarter.
- The company achieved further reductions in costs, including operational and support service expenses.
- The cash balance at the end of the quarter was £5.1 million.
- Overall, DOC's Q1 2023 revenue was £5.0 million, a decrease compared to Q1 2022 (£5.7 million), mainly due to lower video and phone consultations.
- Despite revenue decline, DOC continued to focus on improving gross margins and reducing administrative expenses.
- The company reported progress in product development, including launching a new patient app and digital front door initiatives.
- DOC advanced its partnerships, notably with AXA Health, and expanded its reach by offering new services.
- The company is exploring additional capital options to support its future growth and sustainability.
- DOC received payments from customers totaling £5.0 million during the quarter.
- The quarterly report outlines continued focus on operational efficiencies, cost reductions, and strategic initiatives to drive growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Odessa Minerals Limited (ODE) ORDINARY FULLY PAID |
Materials |
$11 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 9:17AM |
$0.006 |
$0.007 |
risen by
16.67%
|
|
ODE - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly report covers activities for the quarter ending 31 March 2024.
- Odessa completed a maiden drilling program at the Gascoyne East Lithium Project; assays pending.
- Continued work at Aries Diamond Project with bulk sampling and geophysical survey planning.
- Cash balance at quarter end was $2.32 million.
- Appendix 5B details exploration expenditure as the main outflow.
- Minimal spending on administration and staff costs.
- Odessa remains focused on lithium and diamond exploration in Western Australia.
- The company is evaluating further exploration opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cluey Ltd (CLU) ORDINARY FULLY PAID |
Consumer Discretionary |
$29 |
Q4 FY25 Financial Performance & Business Update Presentation
|
31 Jul 2025 9:17AM |
$0.080 |
$0.083 |
risen by
3.75%
|
|
CLU - Price-sensitive ASX Announcement
Full Release
Key Points
- Reported financial performance for Q4 FY25, highlighting revenue growth and improved profitability.
- Outlined operational achievements, including expansion of customer base and new product offerings.
- Discussed the company’s strategic focus on technology-driven education solutions.
- Provided details on cost management, efficiency improvements, and margin expansion.
- Identified challenges faced in the quarter and corresponding management responses.
- Shared outlook for continued growth, innovation, and market expansion.
- Reiterated commitment to educational quality and service delivery.
- Included forward-looking statements regarding business strategy and financial goals.
- Highlighted management’s focus on sustainable, long-term shareholder value.
- Engaged with stakeholders on future initiatives and potential market opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nyrada Inc (NYR) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$61 |
Trading Halt
|
31 Jul 2025 9:16AM |
$0.370 |
$0.290 |
fallen by
21.62%
|
|
NYR - Price-sensitive ASX Announcement
Full Release
Key Points
- Nyrada Inc (ASX:NYR) has requested a trading halt effective 13 June 2024.
- The trading halt is pending an announcement regarding a proposed capital raising.
- The halt will remain until the earlier of normal trading on 17 June 2024 or the announcement release.
- The trading halt aims to ensure orderly trading in Nyrada's securities.
- ASX has confirmed the trading halt at the company's request.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pengana Private Equity Trust (PE1) ORDINARY UNITS FULLY PAID |
Financials |
$360 |
Update - Notification of buy-back - PE1
|
31 Jul 2025 9:16AM |
$1.280 |
$1.310 |
risen by
2.34%
|
|
| Control Bionics Limited (CBL) ORDINARY FULLY PAID |
Health Care |
$11 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2025 9:15AM |
$0.037 |
$0.036 |
fallen by
2.70%
|
|
CBL - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly cash receipts were $1.2 million, showing strong sales in the US and Australia.
- Product rollout included Cosmos Connect and NeuroNode Trilogy, boosting market reach.
- Disciplined cost management maintained, with $5.3 million in cash at quarter-end.
- Strategic focus on commercial partnerships and new marketing initiatives.
- Continued investment in research and development and customer engagement.
- Management committed to progressing towards profitability.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
